Location History:
- Seatte, WA (US) (2006)
- Seattle, WA (US) (1990 - 2023)
Company Filing History:
5 out of 2,104 
1 out of 560 
2 out of 832,880 Years Active: 1990-2023
Title: The Innovations of George Stamatoyannopoulos
Introduction
George Stamatoyannopoulos is a prominent inventor based in Seattle, WA, known for his significant contributions to the field of genomic research. With a total of seven patents to his name, he has made remarkable strides in developing methods and technologies that address critical health issues.
Latest Patents
Among his latest patents is the invention titled "Genomic insulator elements and uses thereof." This patent outlines methods for identifying high potency genomic insulator elements that can be utilized in vector compositions. These elements are particularly useful for preventing unwanted expression of neighboring genes, such as proto-oncogenes, when administered to a subject in need. Additionally, he has developed methods for treating diseases and administering nucleic acids to subjects using such vectors. Another notable patent is "Globin gene therapy for treating hemoglobinopathies." This invention provides expression cassettes that facilitate the expression of a globin gene or a functional portion thereof. It also includes vectors and cells transduced with these expression cassettes, along with methods for treating hemoglobinopathies by administering an effective amount of transduced cells to the subject.
Career Highlights
George has had a distinguished career, primarily associated with the University of Washington. His work has significantly impacted the field of gene therapy and genomic research, leading to advancements that hold promise for treating various genetic disorders.
Collaborations
Throughout his career, George has collaborated with notable colleagues, including John A. Stamatoyannopoulos and Thalia Papayannopoulou. Their combined expertise has contributed to the success of various research projects and innovations.
Conclusion
George Stamatoyannopoulos stands out as a leading inventor in genomic research, with a focus on developing innovative solutions for health challenges. His patents reflect a commitment to advancing medical science and improving patient outcomes.